NCT06496633View on ClinicalTrials.gov

Echocardiography-guided Percutaneous Septal Radiofrequency Ablation for Obstructive HCM After Alcohol Septal Ablation

Active, not recruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

March 26, 2024

Primary Completion Date

October 31, 2024

Study Completion Date

December 31, 2024

Conditions
Hypertrophic Cardiomyopathy
Interventions
PROCEDURE

Percutaneous Intramyocardial Septal Radiofrequency Ablation

PIMSRA procedure represents a significant breakthrough in the treatment of HOCM patients, as it uses a unique transmyocardial approach to directly and precisely insert a radiofrequency electrode needle into the hypertrophied IVS for targeted ablation

Trial Locations (1)

710032

Ultrasonic Diagnosis Department of Xijing Hospital, Fourth Military Medical University, Xi'an

All Listed Sponsors
lead

Xijing Hospital

OTHER

NCT06496633 - Echocardiography-guided Percutaneous Septal Radiofrequency Ablation for Obstructive HCM After Alcohol Septal Ablation | Biotech Hunter | Biotech Hunter